James T Snyder, Ii

Title: James T Snyder, II: Innovator in Viral Treatment

Introduction

James T Snyder, II is a notable inventor based in Phoenix, AZ. He has made significant contributions to the field of medicine, particularly in the development of vaccines and methods for combating drug-resistant viruses. His work is crucial in the ongoing fight against diseases such as HIV-1 and hepatitis B.

Latest Patents

James T Snyder, II holds a patent for "Vaccines and methods for prevention and treatment of drug-resistant HIV-1 and hepatitis B virus." This invention provides methods for lowering the viral load of a virus resistant to antiviral drugs by inducing cytotoxic T lymphocytes (CTL) to recognize a predetermined mutated epitope within a viral protein of the drug-resistant virus. The CTLs are induced by immunizing a host with a peptide that includes the predetermined mutation. The immunostimulating peptide can be further enhanced for inducing specific CTLs. The antiviral protection against drug-resistant viruses demonstrated by the compositions of this invention, mediated by human HLA-restricted CTL, has not been previously achieved.

Career Highlights

James T Snyder, II is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution allows him to contribute to groundbreaking research and advancements in public health.

Collaborations

Some of his notable coworkers include Andrew Catanzaro and Robert Yarchoan, who collaborate with him on various research projects aimed at improving treatment methods for viral infections.

Conclusion

James T Snyder, II is a dedicated inventor whose work in developing innovative treatments for drug-resistant viruses is making a significant impact in the medical field. His contributions are vital in the ongoing battle against viral diseases.